Fierce Fatty Podcast cover image

156: Part 2: Is Wegovy/Ozempic the Miracle Weight Loss Drug It’s Made Out to Be? (Part 2)

Fierce Fatty Podcast

00:00

Allegations of Misconduct in Insulin Pricing and Marketing

This chapter delves into the controversies surrounding Novo Nordisk's promotion of Victoza, including whistleblower claims of deceptive sales practices. It also highlights issues of price inflation and potential collusion among major insulin manufacturers, alongside legal repercussions for antitrust violations.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app